Prevention of oxidant-induced cell death in Caco-2 colon carcinoma cells after inhibition of poly(ADP-ribose) polymerase and Ca2+ chelation:: Involvement of a common mechanism

被引:19
|
作者
Karczewski, JM [1 ]
Peters, JGP [1 ]
Noordhoek, J [1 ]
机构
[1] Univ Nijmegen, Dept Toxicol, NL-6500 HB Nijmegen, Netherlands
关键词
menadione; hydrogen peroxide; DNA damage; calcium; poly(ADP-ribose) polymerase; 3-aminobenzamide;
D O I
10.1016/S0006-2952(98)00286-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The human colon carcinoma cell line Caco-2 was exposed to the oxidative stress-inducing agents menadione (MEN), 2,3-dimethoxy-1,4-naphthoquinone, and hydrogen peroxide. All three agents caused DNA damage which was assessed by alkaline unwinding. Further, all three agents induced intensive NAD(+) depletion, followed by a decrease in intracellular ATP and viability. Inhibition of poly(ADP-ribose) polymerase (PARP, EC 2.4.2.30) by 3-aminobenzamide prevented the depletion of NAD(+). These cells had a higher viability and ATP content. The most pronounced effect was observed with 25 mu M of MEN, while at higher levels a partial preservation of NAD(+) was observed with no effect on ATP or viability. The chelation of intracellular calcium by bis-(o-aminophenoxy)-ethane-N,N,N-1,N-1-tetraacidic acid/tetraacetoxymethyl) ester also prevented the dramatic loss of NAD(+), demonstrating that Ca2+ is an activating factor in PARP-mediated cell killing. (C) 1998 Elsevier Science Inc.
引用
收藏
页码:19 / 26
页数:8
相关论文
共 27 条
  • [1] Purines inhibit poly(ADP-ribose) polymerase activation and modulate oxidant-induced cell death
    Virág, L
    Szabó, C
    FASEB JOURNAL, 2001, 15 (01): : 99 - 107
  • [2] Poly(ADP-ribose)glycohydrolase is an upstream regulator of Ca2+ fluxes in oxidative cell death
    C. Blenn
    P. Wyrsch
    J. Bader
    M. Bollhalder
    Felix R. Althaus
    Cellular and Molecular Life Sciences, 2011, 68 : 1455 - 1466
  • [3] Poly(ADP-ribose)glycohydrolase is an upstream regulator of Ca2+ fluxes in oxidative cell death
    Blenn, C.
    Wyrsch, P.
    Bader, J.
    Bollhalder, M.
    Althaus, Felix R.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2011, 68 (08) : 1455 - 1466
  • [4] A role of the Ca2+/Mg2+-dependent endonuclease in apoptosis and its inhibition by poly(ADP-ribose) polymerase
    Yakovlev, AG
    Wang, GP
    Stoica, BA
    Boulares, HA
    Spoonde, AY
    Yoshihara, K
    Smulson, ME
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (28) : 21302 - 21308
  • [5] Cell Death and Autophagy under Oxidative Stress: Roles of Poly(ADP-Ribose) Polymerases and Ca2+
    Wyrsch, Philippe
    Blenn, Christian
    Bader, Jessica
    Althaus, Felix R.
    MOLECULAR AND CELLULAR BIOLOGY, 2012, 32 (17) : 3541 - 3553
  • [6] Inhibition of poly(ADP-ribose) polymerase activation attenuates β-lapachone-induced necrotic cell death in human osteosarcoma cells
    Liu, TJ
    Lin, SY
    Chau, YP
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2002, 182 (02) : 116 - 125
  • [7] Inhibition of poly(ADP-ribose) polymerase (PARP) influences the mode of sulfur mustard (SM)-induced cell death in HaCaT cells
    Kehe, K.
    Raithel, K.
    Kreppel, H.
    Jochum, M.
    Worek, F.
    Thiermann, H.
    ARCHIVES OF TOXICOLOGY, 2008, 82 (07) : 461 - 470
  • [8] Inhibition of poly(ADP-ribose) polymerase (PARP) influences the mode of sulfur mustard (SM)-induced cell death in HaCaT cells
    K. Kehe
    K. Raithel
    H. Kreppel
    M. Jochum
    F. Worek
    H. Thiermann
    Archives of Toxicology, 2008, 82 : 461 - 470
  • [9] Investigation of Cell Death in Caco-2 Colon Cancer Cells After mTOR Inhibition by Rapamycin
    Ergin, K.
    Aktas, S.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S49 - S49
  • [10] Somatic BRCA1/2 Recovery as a Resistance Mechanism After Exceptional Response to Poly (ADP-ribose) Polymerase Inhibition
    Lheureux, Stephanie
    Bruce, Jeff P.
    Burnier, Julia V.
    Karakasis, Katherine
    Shaw, Patricia A.
    Clarke, Blaise A.
    Yang, S. Y. Cindy
    Quevedo, Rene
    Li, Tiantian
    Dowar, Mark
    Bowering, Valerie
    Pugh, Trevor J.
    Oza, Amit M.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (11) : 1240 - 1249